
Sign up to save your podcasts
Or


Interesting trial this week evaluating a fixed schedule of rituximab vs. a tailored approach to therapy. See you all at ACR this week!
By Michael Putman4.9
113113 ratings
Interesting trial this week evaluating a fixed schedule of rituximab vs. a tailored approach to therapy. See you all at ACR this week!

323 Listeners

499 Listeners

876 Listeners

131 Listeners

1,146 Listeners

121 Listeners

192 Listeners

172 Listeners

67 Listeners

247 Listeners

4 Listeners

183 Listeners

11 Listeners

18 Listeners

6 Listeners